New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor
Neurology March 07,2024
Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

Lifestyle changes prevent cognitive decline even in genetically susceptible individuals

by University of Eastern FinlandEnhanced lifestyle counselling prevents cognitive decline even in people who are carriers of the APOE4 gene, a common risk factor of Alzheimer's disease, accor
Neurology March 07,2024
Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli
Neurology March 07,2024
Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

Vascular risk factors and Alzheimer's disease—a new therapeutic opportunity?

by IOS PressCurrently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metaboli
Neurology March 07,2024
Alzheimer's detected before symptoms via new eye technology

Alzheimer's detected before symptoms via new eye technology

by Association for Research in Vision and OphthalmologyRockville, Md. Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology t
Neurology March 07,2024
Alzheimer's detected before symptoms via new eye technology

Alzheimer's detected before symptoms via new eye technology

by Association for Research in Vision and OphthalmologyRockville, Md. Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology t
Neurology March 07,2024
Research finds that ultrasound slows brain ageing

Research finds that ultrasound slows brain ageing

by University of QueenslandTreatment with scanning ultrasound has already been proven to reverse Alzheimer's disease in mice, and now it appears it could also slow down ageing in healthy brai
Neurology March 07,2024
Research finds that ultrasound slows brain ageing

Research finds that ultrasound slows brain ageing

by University of QueenslandTreatment with scanning ultrasound has already been proven to reverse Alzheimer's disease in mice, and now it appears it could also slow down ageing in healthy brai
Neurology March 07,2024
Treponema denticola found to induce Alzheimer-like tau hyperphosphorylation in mice

Treponema denticola found to induce Alzheimer-like tau hyperphosphorylation in mice

by International & American Associations for Dental ResearchA study investigating the role of Treponema denticola (T. denticola) in Alzheimer's disease (AD) pathogenesis will be presented by Z
Neurology March 07,2024
Treponema denticola found to induce Alzheimer-like tau hyperphosphorylation in mice

Treponema denticola found to induce Alzheimer-like tau hyperphosphorylation in mice

by International & American Associations for Dental ResearchA study investigating the role of Treponema denticola (T. denticola) in Alzheimer's disease (AD) pathogenesis will be presented by Z
Neurology March 07,2024
Progranulin and dementia—a blood sample does not tell the full story!

Progranulin and dementia—a blood sample does not tell the full story!

by Bentham Science PublishersProgranulin is a central protein in both neuronal survival and neurodegenerative diseases. It is thus not surprising that altered progranulin levels represent a universal
Neurology March 07,2024
Progranulin and dementia—a blood sample does not tell the full story!

Progranulin and dementia—a blood sample does not tell the full story!

by Bentham Science PublishersProgranulin is a central protein in both neuronal survival and neurodegenerative diseases. It is thus not surprising that altered progranulin levels represent a universal
Neurology March 07,2024
Link between common prostate cancer treatment, dementia detailed in new study

Link between common prostate cancer treatment, dementia detailed in new study

by Perelman School of Medicine at the University of PennsylvaniaA new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy
Neurology March 07,2024
Link between common prostate cancer treatment, dementia detailed in new study

Link between common prostate cancer treatment, dementia detailed in new study

by Perelman School of Medicine at the University of PennsylvaniaA new analysis of patients who have undergone treatment for prostate cancer shows a connection between androgen deprivation therapy
Neurology March 07,2024
Researchers use imaging technique to predict dementia status in adults with down syndrome

Researchers use imaging technique to predict dementia status in adults with down syndrome

by Laura Dawahare,University of KentuckyResearchers at the University of Kentucky Sanders-Brown Center on Aging found that magnetic resonance spectroscopy (MRS), a noninvasive imaging technique,
Neurology March 07,2024
Researchers use imaging technique to predict dementia status in adults with down syndrome

Researchers use imaging technique to predict dementia status in adults with down syndrome

by Laura Dawahare,University of KentuckyResearchers at the University of Kentucky Sanders-Brown Center on Aging found that magnetic resonance spectroscopy (MRS), a noninvasive imaging technique,
Neurology March 07,2024
Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei
Neurology March 07,2024
Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

Lack of brain shrinkage may help predict who develops dementia with Lewy bodies

by Mayo ClinicDementia with Lewy bodies is a progressive disease that causes hallucinations, decline in mental abilities, rigid muscles, slow movement and tremors. With symptoms similar to Alzhei
Neurology March 07,2024
Study identifies potential biomarker for Alzheimer's disease

Study identifies potential biomarker for Alzheimer's disease

by Boston University Medical CenterIn one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers h
Neurology March 07,2024
Study identifies potential biomarker for Alzheimer's disease

Study identifies potential biomarker for Alzheimer's disease

by Boston University Medical CenterIn one of the largest studies to date to use metabolomics, the study of compounds that are created through various chemical reactions in the body, researchers h
Neurology March 07,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com